Biomea Fusion (NASDAQ:BMEA) Price Target Lowered to $15.00 at HC Wainwright
Biomea Fusion (NASDAQ:BMEA – Get Free Report) had its price objective dropped by investment analysts at HC Wainwright from $50.00 to $15.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price points to a potential upside of 261.45% from the […]
More Stories
MediciNova, Inc. (NASDAQ:MNOV) Short Interest Up 19.3% in September
MediciNova, Inc. (NASDAQ:MNOV – Get Free Report) was the target of a significant increase in short interest in the month...
Short Interest in Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Grows By 22.8%
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) was the target of a significant increase in short interest in September....
Merck KGaA (OTCMKTS:MKGAF) Short Interest Up 26.9% in September
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) saw a large increase in short interest in the month of September. As...
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) Sees Significant Growth in Short Interest
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Get Free Report) was the recipient of a large increase in short interest in the...
Two Harbors Investment Corp. (NYSE:TWO) Short Interest Up 17.5% in September
Two Harbors Investment Corp. (NYSE:TWO – Get Free Report) saw a significant increase in short interest in September. As of...
World News in Brief: Possible ‘dire consequences’ for Yemen following strikes, Ukraine hospital attack, human rights in Algeria
UN humanitarians on Monday warned of the potentially dire consequences that could arise from disruption to the flow of food...